Dermavant Sciences Gmbh

Allergan Pharmaceuticals International Limited

Stiefel Laboratories, Inc.

Stiefel Research Australia Pty Ltd

Palau Pharma, S.a.

Jon Lenn

Michael Quinn Doherty

Joey Roger Thomas

Leandro Santos

Justin Whiteman

Mary Bedard

Piyush Jain

Hans Hofland

Edward Hsia

Barry Hunt

The present invention relates to topical pharmaceutical emulsion compositions comprising a therapeutically effective amount of 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a pharmaceutically acceptable salt thereof, an oil phase, a water phase, a surfactant, and an antioxidant, and wherein the emulsion composition is homogeneous and/or the active is solubilized in the oil phase. The invention also relates to methods of treating a dermatological condition or disorder in a patient by administering the present compositions to the skin of the patient.

Topical pharmaceutical compositions

The present invention relates generally to antifugal compositions. In an embodiment, the antifungal compositions are effective for application to nails and surrounding skin, and comprise at least one volatile solvent, at least one film forming substance, and at least one pyrimidone derivative of formula I, such as albaconazole. These compositions are capable of treating an infection caused by fungi, such as onychomychosis.

Azole antifungal compositions

Growing community of inventors

Durham, NC, United States of America

Jon Lenn